Pancreas transplantation with ATG vs OKT3

被引：3
|
作者：
Rosenberg, L [1 ]
机构：
[1] MCGILL UNIV,MONTREAL,PQ,CANADA
来源：
TRANSPLANTATION PROCEEDINGS | 1997年 / 29卷 / 7A期
关键词：
D O I：
10.1016/S0041-1345(97)00630-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 50 条
  • [1] EXPERIENCE WITH OKT3 IN VASCULARIZED PANCREAS TRANSPLANTATION
    SOLLINGER, HW
    STRATTA, RJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) : 145 - 148
  • [2] Cancer risk associated with ATG/OKT3 in renal transplantation
    Hibberd, AD
    Trevillian, PR
    Wlodarzcyk, JH
    Gillies, AHB
    Stein, AM
    Sheil, AGR
    Disney, APS
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1271 - 1272
  • [3] OKT3 VS ALG INDUCTION THERAPY IN COMBINED PANCREAS-KIDNEY TRANSPLANTATION
    KNECHTLE, SJ
    PIRSCH, JD
    GROSHEK, M
    REED, A
    DALESSANDRO, AM
    KALAYOGLU, M
    BELZER, FO
    SOLLINGER, HW
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1581 - 1582
  • [4] USE OF OKT3 IN KIDNEY, PANCREAS, AND LIVER-TRANSPLANTATION
    DALESSANDRO, AM
    PIRSCH, JD
    MELZER, JS
    SOLLINGER, HW
    KALAYOGLU, M
    REED, A
    KNECHTLE, SJ
    BELZER, FO
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) : 1748 - 1749
  • [5] Basiliximab vs OKT3 in liver transplantation.
    Elkhalammas, EA
    Henry, ML
    Demirag, A
    Carmona, MM
    Bumgardner, GL
    Pelletier, RP
    Feguson, RM
    TRANSPLANTATION, 2000, 69 (08) : S167 - S167
  • [6] OKT3 THERAPY IN KIDNEY, LIVER, HEART, AND PANCREAS TRANSPLANTATION
    FIRST, MR
    SCHROEDER, TJ
    MELVIN, DB
    MUNDA, R
    FIDLER, JP
    BALISTRERI, WF
    HURTUBISE, PE
    ALEXANDER, JW
    PENN, I
    RYCKMAN, FC
    CLINICAL TRANSPLANTATION, 1988, 2 (04) : 185 - 189
  • [7] COMPARISON OF CYA, OKT3, AND ATG IMMUNOPROPHYLAXIS IN HUMAN LIVER-TRANSPLANTATION
    STEININGER, R
    MUHLBACHER, F
    HAMILTON, G
    LANGLE, F
    GNANT, M
    POPOW, T
    SAUTNER, T
    GOTZINGER, P
    WAMSER, P
    STOCKENHUBER, F
    MIRZA, D
    PIZA, F
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (04) : 2269 - 2271
  • [8] Zenapax versus OKT3 as induction for solitary pancreas transplantation.
    Innocenti, FA
    Larson, TS
    Gloor, JM
    Velosa, JA
    Hughes, CB
    Sterioff, S
    Nyberg, SL
    Stegall, MD
    TRANSPLANTATION, 1999, 67 (09) : S627 - S627
  • [9] PROPHYLACTIC CYTOLYTIC TREATMENT AFTER HEART-TRANSPLANTATION - ATG VERSUS OKT3
    LASKE, A
    LEONARDI, L
    GALLINO, A
    BAUER, E
    CARREL, T
    SCHONBECK, M
    VONSEGESSER, LK
    TURINA, M
    HELVETICA CHIRURGICA ACTA, 1991, 57 (04) : 611 - 617
  • [10] The influence of the immunosuppressants OKT3 and ATG on immunological parameters
    Neumann, MC
    Muller, TF
    Sprenger, H
    Gemsa, D
    Lange, H
    CLINICAL NEPHROLOGY, 1996, 45 (05) : 345 - 348
12345